Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic - Wikidata - wikimedia - TriplyDB

Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic

Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic

http://www.wikidata.org/entity/Q30300019

about

Oncolytic adenovirus-mediated therapy for prostate cancer MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice Matricellular protein CCN1 mediates doxorubicin-induced cardiomyopathy in mice.Recent advances in oncolytic adenovirus therapies for cancer.Detecting Tumor Metastases: The Road to Therapy Starts Here.Enhanced tumor growth inhibition by mesenchymal stem cells derived from iPSCs with targeted integration of interleukin24 into rDNA loci.Novel therapy of prostate cancer employing a combination of viral-based immunotherapy and a small molecule BH3 mimetic.Targeting strategies of adenovirus‑mediated gene therapy and virotherapy for prostate cancer (Review).Viral Vectors, Engineered Cells and the CRISPR Revolution.Cancer Terminator Viruses (CTV): A Better Solution for Viral-Based Therapy of Cancer.

P2860

Q27004796-53B5FCE5-7B12-41A3-B1BF-65B86AE194E9 Q36545635-CA0831A8-BA74-45F9-BE01-09B75F4C9D15 Q36545638-0132374C-3319-4A62-8042-F100480181F4 Q37392811-F1561EEF-D32B-413C-9608-BD1C3E40E4A6 Q38886593-B0FBAC1A-25F2-41AE-8B3C-5F31E0FE503A Q38950545-9454350B-0980-4E35-AA37-4B3AC20F9B8D Q40253067-13B73C5D-9AF2-4C91-8F9F-4B9C61EE7A85 Q40437589-376F50BD-2A18-411C-9E3A-021839647EC8 Q45871873-6398C9D4-ED39-45A4-A2B9-47B44FD9F35B Q45874356-7C9F72DF-06E9-4F2B-A843-8355F054ED3C Q47560447-9E8FB422-A0AB-4066-9FA1-596C828DB1A1

P2860

Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic

http://www.wikidata.org/entity/Q30300019

description

2015 nî lūn-bûn

@nan

2015 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Therapy of prostate cancer usi ...... a small molecule BH-3 mimetic

@ast

Therapy of prostate cancer usi ...... a small molecule BH-3 mimetic

@en

type

label

Therapy of prostate cancer usi ...... a small molecule BH-3 mimetic

@ast

Therapy of prostate cancer usi ...... a small molecule BH-3 mimetic

@en

prefLabel

Therapy of prostate cancer usi ...... a small molecule BH-3 mimetic

@ast

Therapy of prostate cancer usi ...... a small molecule BH-3 mimetic

@en

P1433

Q30300019-3DB8F664-E711-4BF3-B148-1AA61B3A39C5

P1476

Q30300019-9A5250F5-4FE5-41E7-B323-7DD56B69145D

P2093

Q30300019-21766739-5F48-427B-AF97-B5CFCC0DD4E8

Q30300019-3A609733-19A4-4051-B93B-BEA5096CF695

Q30300019-5398790C-BAE1-4E1F-B58C-4671BD3601AE

Q30300019-63E6B843-DA77-4505-8EF7-19237034117A

Q30300019-77B76929-F758-41CD-87D2-00A38B573232

Q30300019-8B6AF9B2-47B2-4389-B1CE-A7B7520450AA

Q30300019-8FF03A65-D408-43A6-80A9-C5CBEDFA9608

Q30300019-BC45030D-0534-4F08-9139-9DBEFF2EC1B0

Q30300019-C5B55BA3-1C81-4A5B-A4C3-8E2BADE608E7

Q30300019-E0D2E27A-9987-47BA-9D98-2F1492932933

P2860

Q30300019-05B58B57-E8FB-4EA6-8E43-19C54485D554

Q30300019-0955504A-8041-4F0B-BD40-2F699E702DEB

Q30300019-0CD6BBF2-2603-4509-8B60-EE1D57EFD438

Q30300019-0F16137E-ED94-4C53-BA43-DC76BB5B25E5

Q30300019-112C6804-1046-4B9A-B57D-D51E7861D839

Q30300019-14771EFC-43E8-46DB-8DBF-B1BF8BBE3E9F

Q30300019-177B27C2-F26C-4828-9A37-0BEA644A5FF8

Q30300019-19796BB3-4AF9-426A-BB3A-26992D2396E9

Q30300019-1B175AD4-5DFC-4FBD-921B-1D5511352663

Q30300019-20793A83-6FB8-432F-8E62-AEC0EB88F2A1

P304

Q30300019-38E4B52A-9E11-4070-A892-76A024E9DA7E

P31

Q30300019-44B5E075-4861-4B23-AB09-2ECC51B1FCA6

P356

Q30300019-CC4D90D9-C896-4629-AD11-C151C22255F4

P407

Q30300019-A7BA60C9-C4B5-4885-AD89-D8166C477D62

P433

Q30300019-21CCF3F4-95FF-4D61-9BB0-6AC362FE7DE4

P478

Q30300019-0CD275A2-F0B1-40EA-A830-1618B351FE92

P50

Q30300019-6E6A53BC-761A-4F7D-AED0-0FD27D8968F9

P577

Q30300019-7BA96319-6D08-49B2-8D84-0E67AA9B7449

P5875

Q30300019-7D752ACF-BFBB-4F55-96D4-D2D00426BF94

P698

Q30300019-7DDDF8B0-18C9-4078-8791-9C14E25DD38D

P932

Q30300019-09A0C3FA-29CF-4492-89BF-4ED86D5A8A8C

P356

ONCOTARGET.3544

P1433

P1476

Therapy of prostate cancer usi ...... a small molecule BH-3 mimetic

@en

P2093

Alexander L Klibanov

http://www.w3.org/2001/XMLSchema#string

Bridget A Quinn

http://www.w3.org/2001/XMLSchema#string

Devanand Sarkar

http://www.w3.org/2001/XMLSchema#string

Luni Emdad

http://www.w3.org/2001/XMLSchema#string

Paul B Fisher

http://www.w3.org/2001/XMLSchema#string

Rupesh Dash

http://www.w3.org/2001/XMLSchema#string

Siddik Sarkar

http://www.w3.org/2001/XMLSchema#string

Swadesh K Das

http://www.w3.org/2001/XMLSchema#string

Xiang-Yang Wang

http://www.w3.org/2001/XMLSchema#string

Xue-Ning Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.

Expression of cyr61, a growth factor-inducible immediate-early gene

Targeting Mcl-1 for the therapy of cancer

Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic

Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.

Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow.

Insonation of targeted microbubbles produces regions of reduced blood flow within tumor vasculature.

Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach.

Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter.

A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy.

P304

10712-10727

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3544

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Maurizio Pellecchia

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275667281

http://www.w3.org/2001/XMLSchema#string

P698

25926554

http://www.w3.org/2001/XMLSchema#string

P932

4484414

http://www.w3.org/2001/XMLSchema#string